1. Lack of RAD51 foci formation enables the identification of PARP inhibitor sensitive breast tumors. (December 2016) Authors: Castroviejo-Bermejo, M.; Cruz, C.; Guerra, S.; Llop-Guevara, A.; Gutiérrez-Enríquez, S.; Bruna, A.; Rubio, I.T.; Oakin, A.; Nucíforo, P.; Díez, O.; Arribas, J.; Judde, J.G.; Caldas, C.; Baselga, J.; Cortés, J.; Balmaña, J.; Saura, C.; O'Connor, M.J.; Cairo, S.; Serra, V. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P398: DEVELOPMENT AND CHARACTERIZATION OF PRECLINICAL IN VIVO MODELS FOR THE IDENTIFICATION AND TESTING OF NEW THERAPEUTIC APPROACHES FOR PEDIATRIC ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Da Ros, A.; Indio, V.; Porcù, E.; Borella, G.; Benetton, M.; Tregnago, C.; Longo, G.; Cairo, S.; Michielotto, B.; Bresolin, S.; Buldini, B.; Pession, A.; Locatelli, F.; Pigazzi, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗